CI
JAZZ icon

Cowen Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cowen Inc’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,000
Closed -$352K – 349
2015
Q2 		$352K Sell
2,000
-250
-11% -$44.9K 0.02% 277
2015
Q1 		$389K Sell
2,250
-550
-20% -$94.4K 0.03% 244
2014
Q4 		$458K Sell
2,800
-250
-8% -$41.5K 0.04% 152
2014
Q3 		$490K Sell
3,050
-1,000
-25% -$154K 0.05% 189
2014
Q2 		$595K Buy
4,050
+625
+18% +$86.7K 0.07% 166
2014
Q1 		$475K Buy
+3,425
New +$516K 0.06% 139

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cowen Inc's JAZZ Position: Q3 2015 in Review

Cowen Inc sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2015, closing a stake of 2,000 shares — an estimated $352K sold.

Cowen Inc first reported a position in JAZZ in Q1 2014 and held it in 6 quarters. The position peaked at $595K in Q2 2014. 360 funds tracked by Wall St. Rank hold JAZZ as of Q3 2015.

  • Cowen Inc reported no remaining Jazz Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Cowen Inc sold 2,000 Jazz Pharmaceuticals shares in Q3 2015, an estimated $352K.
  • Cowen Inc first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 6 quarters.
  • Cowen Inc's Jazz Pharmaceuticals position peaked at $595K in Q2 2014.
  • 360 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.